Biorobotics: an Instrument for an Improved Quality of Life.

May 21, 2018

This paper deals with the developed researches of biorobotics, as an instrument for the maintenance of the quality of human senses, complete control of the nervous system, activation of neuron circuits, recovery of damaged neuromotor functions, rehabilitation of vocal chords, and neuromotor system control following devastating diseases such as Parkinson’s and Alzheimer’s.

Spotlight

Bode Cellmark Forensics

We are pleased to introduce Bode Cellmark Forensics, a new brand that combines the market-leading brands, solutions and teams of Bode Technology and Cellmark Forensics.

OTHER WHITEPAPERS
news image

Impurity profiling and analysis of TheraPure GMP nucleotides

whitePaper | March 22, 2023

Nucleoside triphosphates (NTPs) are key building blocks of many nucleic acid therapeutics and vaccines. These molecules are a vital component of revolutionary new medicines.

Read More
news image

Quality Control Solutions for Cell and Gene Therapy

whitePaper | September 10, 2022

Droplet Digital PCR (ddPCR) provides highly precise and absolute quantification of nucleic acids by counting nucleic acid molecules encapsulated in discrete water-in-oil droplets.

Read More
news image

Improve Your Gene-Editing Success With CRISPR-SNIPER Technology

whitePaper | February 15, 2023

The discovery of both CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated proteins, the Cas nucleases, has revolutionized the field of gene-editing.

Read More
news image

2022 Global Life Sciences Outlook

whitePaper | January 7, 2022

While valuations for the life sciences sector in this past year have been mixed, the underlying performance and outlook for the sector is healthy

Read More
news image

2022 Biosimilars Report: The U.S. Journey and Path Ahead

whitePaper | June 8, 2022

Cardinal Health is fortunate to sit at the crossroads of the United States (U.S.) healthcare system, engaging with stakeholders from across the industry including healthcare

Read More
news image

State of the Global Biotech Landscape

whitePaper | November 22, 2022

Over the last five years, the global biotech and pharmaceutical landscape has witnessed continued growth. The analysis period encompasses a unique timeframe including the global COVID-19 pandemic.

Read More

Spotlight

Bode Cellmark Forensics

We are pleased to introduce Bode Cellmark Forensics, a new brand that combines the market-leading brands, solutions and teams of Bode Technology and Cellmark Forensics.

Events